Taiwan FDA registration 25c8a47893a3f8636c39e1f60ea3608f
Thys red blood cell sedimentation rate quality solution
TW: 蒂艾思紅血球沉降速率品管液
Taiwan·Risk Class 2·DIESSE DIAGNOSTICA SENESE S.P.A.·Registered Jun 22, 2009 – Jun 22, 2019CancelledRegistration details
- Analysis ID
- 25c8a47893a3f8636c39e1f60ea3608f
- Customs Code
- DHA00602034302
Company information
- Manufacturer
- DIESSE DIAGNOSTICA SENESE S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- GRANT TECHNOLOGY CO., LTD.
Product details
- Intended Use
- Red blood cell sedimentation rate measurement and quality control purposes.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.8625 Hematology Quality Control Mixtures
- Import Information
- import
Dates and status
- Registration Date
- Jun 22, 2009
- Expiry Date
- Jun 22, 2019
- Cancellation Date
- Aug 05, 2022
Cancellation information
- Status
- Logged out
- Reason
- 未展延而逾期者
About this record
Access comprehensive regulatory information for Thys red blood cell sedimentation rate quality solution in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 25c8a47893a3f8636c39e1f60ea3608f and manufactured by DIESSE DIAGNOSTICA SENESE S.P.A.. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices